AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimefide M 1 FT Tablet

Prescription Icon
Prescription Required

Marketer

Fidelity Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimefide M 1 FT Tablet

DiaBeta Duo 1mg/500mcg tablet is an antidiabetic medication combining two active agents for managing type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Always take DiaBeta Duo with food, consistently at the same time daily for optimal effectiveness. Your physician will determine the appropriate dosage, potentially adjusting it based on your blood sugar response. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. DiaBeta Duo is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them; maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption can heighten hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before starting treatment; its suitability may be affected. Pregnant or lactating individuals must consult their physician before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are necessary.

Uses of Glimefide M 1 FT Tablet

Managing type 2 diabetes

Major Benefits of Glimefide M 1 FT Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimefide M 1 FT Tablet with a meal.

Common Side effects of Glimefide M 1 FT Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimefide M 1 FT Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimefide M 1 FT Tablet should be administered with a meal.

How Glimefide M 1 FT Tablet works:

Glimefide M 1 FT Tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glimefide M 1 FT Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimefide M 1 FT Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Glimefide M 1 FT Tablet are incompatible; use during breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimefide M 1 FT Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimefide M 1 FT Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, Glimefide M 1 FT Tablet is typically initiated at a low dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimefide M 1 FT Tablet :

Should you forget to take your Glimefide M 1 FT Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimefide M 1 FT Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimefide M 1 FT Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimefide M 1 FT Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimefide M 1 FT Tablet and seek immediate medical attention.
Glimefide M 1 FT Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimepiride tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimepiride use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimepiride can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimepiride M 1 FT Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimefide M 1 FT Tablet
53
MRP 65
18% off